Clearline Capital LP - Q2 2019 holdings

$205 Million is the total value of Clearline Capital LP's 51 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 210.0% .

 Value Shares↓ Weighting
SATS NewECHOSTAR CORPcl a$11,478,000258,978
+100.0%
5.60%
FLXN BuyFLEXION THERAPEUTICS INC$11,200,000
+61.2%
910,542
+63.6%
5.47%
+50.5%
CNDT BuyCONDUENT INC$10,799,000
+21.7%
1,126,064
+75.5%
5.27%
+13.6%
MYL NewMYLAN N V$9,654,000507,017
+100.0%
4.71%
TIVO BuyTIVO CORP$9,329,000
+106.7%
1,265,789
+161.4%
4.56%
+93.1%
HGV BuyHILTON GRAND VACATIONS INC$8,652,000
+4.6%
271,909
+1.4%
4.22%
-2.3%
SYMC NewSYMANTEC CORP$7,985,000366,942
+100.0%
3.90%
COOP BuyMR COOPER GROUP INC$6,299,000
-6.5%
786,419
+12.0%
3.08%
-12.6%
BC BuyBRUNSWICK CORP$6,017,000
+225.8%
131,123
+257.3%
2.94%
+204.1%
ARMK NewARAMARK$5,269,000146,122
+100.0%
2.57%
SCOR NewCOMSCORE INC$4,867,000943,223
+100.0%
2.38%
PRTY BuyPARTY CITY HOLDCO INC$4,432,000
+51.8%
604,607
+64.5%
2.16%
+41.8%
AVYA BuyAVAYA HLDGS CORP$4,058,000
-23.4%
340,726
+8.2%
1.98%
-28.4%
RLGY BuyREALOGY HLDGS CORP$4,047,000
+301.9%
558,924
+532.9%
1.98%
+275.0%
LGFA NewLIONS GATE ENTMNT CORPcl a vtg$3,994,000326,009
+100.0%
1.95%
DISH NewDISH NETWORK CORPcl a$3,457,00090,000
+100.0%
1.69%
CHNG NewCHANGE HEALTHCARE INC$3,444,000235,869
+100.0%
1.68%
REZI BuyRESIDEO TECHNOLOGIES INC$3,421,000
+135.4%
156,081
+107.2%
1.67%
+119.9%
JACK NewJACK IN THE BOX INC$2,251,00027,660
+100.0%
1.10%
MTSI NewMACOM TECH SOLUTIONS HLDGS I$2,103,000139,017
+100.0%
1.03%
IMGN NewIMMUNOGEN INC$1,527,000703,855
+100.0%
0.75%
OEC NewORION ENGINEERED CARBONS S A$1,495,00069,814
+100.0%
0.73%
CBS NewCBS CORP NEWcl b$1,174,00023,532
+100.0%
0.57%
CARS NewCARS COM INC$652,00033,084
+100.0%
0.32%
COT NewCOTT CORP QUE$638,00047,768
+100.0%
0.31%
TBPH NewTHERAVANCE BIOPHARMA INC$608,00037,258
+100.0%
0.30%
ERI NewELDORADO RESORTS INC$415,0009,000
+100.0%
0.20%
GOGO NewGOGO INC$338,00084,878
+100.0%
0.16%
FOXA NewFOX CORP$324,0008,846
+100.0%
0.16%
SBGI NewSINCLAIR BROADCAST GROUP INCcl a$245,0004,562
+100.0%
0.12%
AMRX NewAMNEAL PHARMACEUTICALS INC$226,00031,479
+100.0%
0.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NCR CORP NEW33Q3 202311.3%
MAGNACHIP SEMICONDUCTOR CORP22Q3 20234.3%
SPECTRUM BRANDS HLDGS INC NE19Q3 202314.3%
MADISON SQUARE GRDN SPRT COR17Q3 20234.3%
BRINKS CO16Q3 20234.7%
CLUBCORP HLDGS INC15Q2 20175.1%
ADVANCE AUTO PARTS INC15Q3 20236.8%
PRIMO WATER CORPORATION15Q3 20234.0%
XEROX HOLDINGS CORP15Q1 20232.6%
MICRON TECHNOLOGY INC14Q4 20223.4%

View Clearline Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Clearline Capital LP Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Clearline Capital LPFebruary 14, 20202,716,8593.9%
Apptio IncApril 07, 2017467,5216.8%

View Clearline Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-15
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Clearline Capital LP's complete filings history.

Compare quarters

Export Clearline Capital LP's holdings